Search Results for

Trump now holds the unique honor of being the first United States president convicted of a felony. This is a golden opportunity for the Biden campaign to highlight the glaring distinction between the candidates: Trump is a corporate criminal hellbent on using the presidency to further the interests of himself and other corporate criminals. President Biden has leveraged executive branch power to dismantle criminal practices that pad the pockets of corporations. After some initial hesitancy to touch on Trump’s conviction, Biden rightly appears poised to make this a forefront issue in the campaign.

Montana’s top legal officer is flying under the national radar, but his scandals and policy agenda mirror his more infamous peers.

In 2022, Biden’s EPA opened an investigation into Louisiana’s Departments of Health (LDH) and Environmental Quality (LDQ) for failing to sufficiently protect residents of “Cancer Alley”—a strip of predominantly poor, Black communities suffering the dire effects of pollutants spewed from nearby petrochemical plants. To their credit, LDH and LDQ cooperated with the investigation and worked to craft more stringent standards and oversight protocols. Former Louisiana Attorney General Jeff Landry, however, had other ideas. His office filed a lawsuit challenging the EPA’s (clear) authority to pursue its investigation under Title VI of the Civil Rights Act, which allows the government to terminate federal funding for an agency found to have engaged in discrimination. Liz Murrill, Landry’s successor, is picking up the torch to carry on his malevolent agenda. 

In October of 2021, the Federal Reserve was embroiled in scandal. The heads of the Boston and Dallas Feds resigned following personal trading scandals that raised concerns about conflicts of interest and lax ethics guidelines. Further reports of potentially inappropriate trading by Chair Jerome Powell and Vice Chair Clarida rocketed across the business media due to these officials’ immense access to sensitive financial information and influence on monetary policy. Despite their decidedly questionable profiteering off pandemic panic, Powell and Clarida have since had their reputations effectively laundered by the media in a whitewashing effort that has attempted to clear them of all wrongdoing. To make matters worse, the Fed’s FOIA office is doing everything in its power to prevent internal documents relating to the scandals from reaching the light of day.

The regulatory authority of the executive branch is under attack, and BigLaw firms stacked with revolvers are on the front lines leading the assault. I’ve previously written about former FTC Commissioner Christine Varney challenging the legitimacy of her former employer on behalf of pharma company Illumina. Lawyers at Latham & Watkins, a firm stacked with revolvers from executive branch agencies, are before the Supreme Court challenging the Chevron Doctrine, which defers to executive agencies’ interpretations when legislative statutes are unclear. The Securities and Exchange Commission’s ability to hold administrative proceedings hangs in the balance as we await the Supreme Court’s decision in SEC v. Jarkesy, where the Fifth Circuit’s ruling decimated the agency’s authority. In a new attack, revolvers on the labor/management relations team at Morgan Lewis & Bockius have their sights set on the plutocrats’ latest target: the National Labor Relations Board.

The FTC has won its lawsuit against Martin Shkreli, the pharmaceutical executive infamous for jacking up the price of the antiparasitic drug Daraprim from $13.50 to $750 overnight in 2015 and later using his ill-gotten fortune to buy an exclusive Wu-Tang Clan album for $2 million. Shkreli is the quintessential corporate ghoul, having already racked up convictions for securities fraud—which resulted in an indefinite ban from the securities industries—and failure to pay $1.26 million in New York state taxes. Now, his price gouging has finally caught up with him, as the FTC successfully argued that he spearheaded an anti-competitive scheme to monopolize the drug. The presiding judge found Shkreli’s conduct to be “egregious, deliberate, repetitive, long-running, and ultimately dangerous,” issuing a $64.6 million fine and imposing a lifetime ban from the pharmaceutical industry. 

RDP Research Assistant KJ Boyle joined the Majority Report with Sam Seder to discuss his piece in The New Republic titled Donald Trump Is No Friend to the Working Class.

It’s no contest: The Biden administration’s labor policies have been dramatically better for ordinary Americans than those of his predecessor.

While former FTC commissioner Noah Phillips defends private equity from antitrust lawsuits, the media attacks current Chair Lina Khan for … doing her job.

As negotiations to prevent a government shutdown heat up once again, Democratic and Republican Representatives in the House are poised to make a play on agency resources.